![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-desktop-header-1gif-4289.gif)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-mobgif-81230.gif)
X
20
Wuhan Grand Hoyo Co., Ltd. Wuhan Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Carbocisteine, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2011-012 - Rev 03
This Chemical Type CEP, issued on June 06, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 885 associated with this CEP further emphasizes